|
General Information
|
|
|
Product
|
IFI27 Antibody Antigenic Blocking Peptide
|
|
Description
|
Antigenic Blocking Peptide Interferon, alpha-inducible protein 27, partial Antibody C-epitope
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide
|
|
Accession #
|
NCBI: NP_005523.3
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
C-epitope
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
UPI000019A7CD
|
|
Overview
|
Promotes cell death. Mediates IFN-induced apoptosis characterized by a rapid and robust release of cytochrome C from the mitochondria and activation of BAX and caspases 2, 3, 6, 8 and 9.
|
|
Molecular Function
|
Lamin binding; RNA polymerase II activating transcription factor binding
|
|
Subcellular Location
|
Mitochondrion; Multi-pass membrane protein
|
|
Expression
|
Up-regulated by interferons
|
|
Structure
|
Belongs to the IFI6/IFI27 family.
|
|
Alternative Nomenclature
|
2310061N23Rik antibody
FAM14D antibody
IFI 27 antibody
Interferon alpha induced 11.5 kDa protein antibody
Interferon inducible protein 27 antibody
interferon-stimulated gene 12 antibody
ISG 12 antibody
ISG12A antibody
P27 antibody
|
| |
|
IFI27 Antibody
IFI27 Antibody FITC
IFI27 Antibody BIOTIN
IFI27 Positive Control
